Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism

Recruiting now · Phase 1/Phase 2

Conditions studied: Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma

In brief

This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-Pentixafor PET imaging in patients with primary aldosteronism. And evaluates the potential of Al18F-NOTA-Pentixafor PET imaging in surgical strategy guidance.

Key facts

Study ID
NCT06773663
Run by
Peking Union Medical College Hospital
People needed
150
Starts
2023-12-30
Expected to finish
2026-10-30
Last updated by the study team
2025-02-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.